Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Arthritis, Rheumatoid × Radioimmunodetection × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Burkitt Lymphoma 2 Spondylarthritis 1 Rectal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

Adalimumab 14 Etanercept 13 Methotrexate 9 tocilizumab 7 golimumab 6 Infliximab 6 tofacitinib 5 Rituximab 5 Tumor Necrosis Factor Inhibitors 4 Abatacept 4 olokizumab 3 Certolizumab Pegol 3 RC-18 2 Nivolumab 2 Antirheumatic Agents 2 veltuzumab 1 upadacitinib 1 secukinumab 1 sarilumab 1 mavrilimumab 1 entecavir 1 baricitinib 1 andecaliximab 1 Vitamin D 1 Surveys and Questionnaires 1 Sulfasalazine 1 Standard of Care 1 Specimen Handling 1 Saline Solution 1 Radioimmunodetection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01590966 2019-08-26

SCINTRA

University Hospital, Ghent

Phase 3 Completed

Arthritis, Rheumatoid, Spondylarthritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡